Annexon Biosciences's total assets for Q4 2025 were $277.57M, an increase of 21.13% from the previous quarter. ANNX total liabilities were $65.92M for the fiscal quarter, a -2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.